These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16836307)

  • 1. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
    Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W
    Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

  • 4. Ozonolysis applications in drug synthesis.
    Van Ornum SG; Champeau RM; Pariza R
    Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
    [No Abstract]   [Full Text] [Related]  

  • 5. March of the synthesis machines.
    Sanderson K
    Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
    [No Abstract]   [Full Text] [Related]  

  • 6. Organolithium reagents in pharmaceutical asymmetric processes.
    Wu G; Huang M
    Chem Rev; 2006 Jul; 106(7):2596-616. PubMed ID: 16836294
    [No Abstract]   [Full Text] [Related]  

  • 7. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the scope of crystal form evaluation in pharmaceutical science.
    Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
    J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation.
    Moribe K; Tozuka Y; Yamamoto K
    Adv Drug Deliv Rev; 2008 Feb; 60(3):328-38. PubMed ID: 18006109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making medicinal chemistry more effective--application of Lean Sigma to improve processes, speed and quality.
    Andersson S; Armstrong A; Björe A; Bowker S; Chapman S; Davies R; Donald C; Egner B; Elebring T; Holmqvist S; Inghardt T; Johannesson P; Johansson M; Johnstone C; Kemmitt P; Kihlberg J; Korsgren P; Lemurell M; Moore J; Pettersson JA; Pointon H; Pontén F; Schofield P; Selmi N; Whittamore P
    Drug Discov Today; 2009 Jun; 14(11-12):598-604. PubMed ID: 19508922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.
    Brown CK; Friedel HD; Barker AR; Buhse LF; Keitel S; Cecil TL; Kraemer J; Morris JM; Reppas C; Stickelmeyer MP; Yomota C; Shah VP
    AAPS PharmSciTech; 2011 Jun; 12(2):782-94. PubMed ID: 21688063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions.
    Cole KP; Groh JM; Johnson MD; Burcham CL; Campbell BM; Diseroad WD; Heller MR; Howell JR; Kallman NJ; Koenig TM; May SA; Miller RD; Mitchell D; Myers DP; Myers SS; Phillips JL; Polster CS; White TD; Cashman J; Hurley D; Moylan R; Sheehan P; Spencer RD; Desmond K; Desmond P; Gowran O
    Science; 2017 Jun; 356(6343):1144-1150. PubMed ID: 28619938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process chemistry: The science, business, logic, and logistics.
    Zhang TY
    Chem Rev; 2006 Jul; 106(7):2583-95. PubMed ID: 16836293
    [No Abstract]   [Full Text] [Related]  

  • 17. Europe's sweeping chemical law puts medicines in peril.
    Keim B
    Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17297677
    [No Abstract]   [Full Text] [Related]  

  • 18. Are pharmaceutics really going supercritical?
    Pasquali I; Bettini R
    Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.